GRFS
Grifols, S.A.
NASDAQ · Healthcare · Drug Manufacturers - General · ES
$7.80
−1.02%Forward multiples
Based on analyst estimates
- P/E forward
- 10.53x
- P/E 2026E
- 8.01x
- P/E 2027E
- 6.26x
- P/E 2028E
- 4.76x
- P/S forward
- 0.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- 10.01x
- PEG TTM
- 0.45x
- Price / book
- 0.82x
- Price / sales
- 0.61x
- Price / cash flow
- 4.17x
Enterprise value
- Enterprise value
- $17.4B
- EV / sales
- 2.02x
- EV / EBITDA
- 8.57x
- EV / EBIT
- 12.11x
- Market cap
- $5.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026